您的位置: 首页 > 农业专利 > 详情页

Fused pyrroles as IP receptor agonists for the treatment of pulmonary arterial hypertension (PAH) and related disorders
专利权人:
Novartis AG
发明人:
LEBLANC, Catherine,ADCOCK, Claire
申请号:
ES13705578
公开号:
ES2565826T3
申请日:
2013.01.11
申请国别(地区):
ES
年份:
2016
代理人:
摘要:
A compound represented by the formula ** Formula ** or a pharmaceutically acceptable salt thereof, wherein A is N or CR '; R 'is H, C1-C8 alkyl optionally substituted by one or more halogen atoms; R1 is selected from H; C1-C8 alkyl optionally substituted by one or more halogen atoms, OH, C1-C4 alkoxy, C3-C7 cycloalkyl or C3-C7 cycloalkyloxy; - (C2-C4 alkyl) -NR19R21 and C3-C7 cycloalkyl; or R1 is -X-Y; or R1 is -W-R7-X-Y; or R1 is -S (O) 2-X-Y; or R1 is -S (O) 2-W-R7-X-Y; R2 is selected from H; C1-C8 alkyl optionally substituted by one or more halogen atoms, OH, C1-C4 alkoxy, C3-C7 cycloalkyl or C3-C7 cycloalkyloxy; C1-C4 alkoxy; - (C0-C4 alkyl) -NR19R21 and C3-C7 cycloalkyl; or R2 is -X-Y; or R2 is -W-R7-X-Y; or R2 is -S (O) 2-X-Y; or R2 is -S (O) 2-W-R7-X-Y; R2a is selected from H; C1-C8 alkyl optionally substituted by one or more halogen atoms, OH, C1-C4 alkoxy, C3-C7 cycloalkyl or C3-C7 cycloalkyloxy; and C3-C7 cycloalkyl; or R2 and R2a taken together are oxo; wherein one of R1 and R2 is -X-Y, -W-R7-X-Y, -S (O) 2-X-Y; or -S (O) 2-W-R7-X-Y; R3 is independently selected from H; C1-C8 alkyl optionally substituted by one or more halogen atoms, OH, C1-C4 alkoxy, C3-C7 cycloalkyl or C3-C7 cycloalkyloxy; -OH; OR '; - (C0-C4 alkyl) -NR19R21; CN; halogen; - (C0-C4 alkyl) -C6-C14 aryl; - (C0-C4 alkyl) -heteroaryl of 4 to 14 members; -C (>; = O) H; -C (>; = O) OH; - C (>; = O) NR19R21 and C3-C7 cycloalkyl, wherein the aryl and heteroaryl are optionally substituted by one or more substituents independently selected from OH, C1-C4 alkyl, C1-C4 alkoxy, halogens and C1-C4 haloalkyl; R3a is selected from H; C1-C8 alkyl optionally substituted by one or more halogen atoms, OH, C1-C4 alkoxy, C3-C7 cycloalkyl or C3-C7 cycloalkyloxy; and C3-C7 cycloalkyl; or R3 and R3a taken together are oxo; R5 and R6 are independently selected from - (C0-C4 alkyl) -C6-C14 alkyl and - (C0-C4 alkyl) - 4-14 membered heteroaryl, wherein the aryl and heteroaryl are each optionally substituted by
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充